Oritavancin Interactions
There are 174 drugs known to interact with oritavancin, along with 4 disease interactions. Of the total drug interactions, 11 are major, 151 are moderate, and 12 are minor.
- View all 174 medications that may interact with oritavancin
- View oritavancin disease interactions (4)
Most frequently checked interactions
View interaction reports for oritavancin and the medicines listed below.
- Activated Charcoal (charcoal)
- Augmentin (amoxicillin / clavulanate)
- Bactrim (sulfamethoxazole / trimethoprim)
- Byvalson (nebivolol / valsartan)
- Cipro (ciprofloxacin)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Dextrose (glucose)
- Diltiazem Hydrochloride SR (diltiazem)
- Estrogel (estradiol)
- Glycerol (glycerin)
- Heparin Sodium (heparin)
- Inflectra (infliximab)
- Iodides (sodium iodide)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Maalox Advanced Regular Strength (aluminum hydroxide / magnesium hydroxide / simethicone)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Retinol (vitamin a topical)
- Rutin (bioflavonoids)
- Sotalol Hydrochloride AF (sotalol)
- Sovaldi (sofosbuvir)
- Synthroid (levothyroxine)
- Valproate Sodium (valproic acid)
Oritavancin disease interactions
There are 4 disease interactions with oritavancin which include:
Report options
QR code containing a link to this page
More about oritavancin
- oritavancin consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: glycopeptide antibiotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
